IT1126405B - Derivati esteri dell'acido farnesilacetico - Google Patents
Derivati esteri dell'acido farnesilaceticoInfo
- Publication number
- IT1126405B IT1126405B IT27613/79A IT2761379A IT1126405B IT 1126405 B IT1126405 B IT 1126405B IT 27613/79 A IT27613/79 A IT 27613/79A IT 2761379 A IT2761379 A IT 2761379A IT 1126405 B IT1126405 B IT 1126405B
- Authority
- IT
- Italy
- Prior art keywords
- farnesilacetic
- acid
- foreign
- derivatives
- foreign derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14762278A JPS5573642A (en) | 1978-11-28 | 1978-11-28 | Farnesyl-acetic ester derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
IT7927613A0 IT7927613A0 (it) | 1979-11-27 |
IT1126405B true IT1126405B (it) | 1986-05-21 |
Family
ID=15434480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT27613/79A IT1126405B (it) | 1978-11-28 | 1979-11-27 | Derivati esteri dell'acido farnesilacetico |
Country Status (7)
Country | Link |
---|---|
US (1) | US4289786A (it) |
JP (1) | JPS5573642A (it) |
CH (1) | CH646411A5 (it) |
DE (1) | DE2947775A1 (it) |
FR (1) | FR2442829A1 (it) |
GB (1) | GB2039476B (it) |
IT (1) | IT1126405B (it) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4120916A1 (de) * | 1991-06-25 | 1993-01-07 | Basf Ag | Omega-3 mehrfach ungesaettigte fettsaeurederivate, ihre herstellung und verwendung |
WO1995008976A1 (en) * | 1993-09-30 | 1995-04-06 | The Procter & Gamble Company | Active substance delivery system |
US6005086A (en) * | 1995-01-13 | 1999-12-21 | The Salk Institute For Biological Studies | Farnesoid activated receptor polypeptides, and nucleic acid encoding the same |
JP2002519305A (ja) * | 1998-06-24 | 2002-07-02 | メルク エンド カムパニー インコーポレーテッド | 骨吸収阻害用の組成物および方法 |
AU2002214267A1 (en) * | 2000-11-08 | 2002-05-21 | Santen Pharmaceutical Co. Ltd. | Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB938712A (en) * | 1961-05-24 | 1963-10-02 | Angeli Inst Spa | Farnesyl acetic esters |
CA970365A (en) | 1972-07-14 | 1975-07-01 | Princeton Biomedix | Pharmaceutically useful compounds and methods of producing and using same |
US3928403A (en) * | 1974-07-10 | 1975-12-23 | Kuraray Co | Process for preparing farnesyl acetic acid esters and 2-substituted-products thereof |
JPS5855129B2 (ja) * | 1974-11-21 | 1983-12-08 | 株式会社クラレ | 2−置換または無置換のゲラニル酢酸エステル類の製造方法 |
-
1978
- 1978-11-28 JP JP14762278A patent/JPS5573642A/ja active Granted
-
1979
- 1979-11-21 US US06/096,570 patent/US4289786A/en not_active Expired - Lifetime
- 1979-11-27 FR FR7929170A patent/FR2442829A1/fr active Granted
- 1979-11-27 CH CH1054079A patent/CH646411A5/fr not_active IP Right Cessation
- 1979-11-27 GB GB7940873A patent/GB2039476B/en not_active Expired
- 1979-11-27 IT IT27613/79A patent/IT1126405B/it active
- 1979-11-27 DE DE19792947775 patent/DE2947775A1/de active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2442829A1 (fr) | 1980-06-27 |
CH646411A5 (fr) | 1984-11-30 |
DE2947775C2 (it) | 1987-08-27 |
DE2947775A1 (de) | 1980-05-29 |
JPS5573642A (en) | 1980-06-03 |
GB2039476A (en) | 1980-08-13 |
IT7927613A0 (it) | 1979-11-27 |
US4289786A (en) | 1981-09-15 |
GB2039476B (en) | 1982-09-22 |
FR2442829B1 (it) | 1983-07-18 |
JPS6123178B2 (it) | 1986-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1166909B (it) | Derivati dell'acido chinolin*carbossilico sostituiti | |
IT1097233B (it) | Nuovi derivati dell'acido fenilacetico | |
IT1202822B (it) | Derivati esterei dell'acido n-acetil-para-aminofenolico e loro preparazione | |
IT1138193B (it) | Derivati dell'acido carbammico | |
IT1170915B (it) | Derivati sostituiti dell'acido 4-fenil-4-osso-2-butenoico aventi proprieta' farmaceutiche | |
IT1124869B (it) | Procedimento per la produzione di derivati dell'acido fenossicarbossilico | |
IT8123108A1 (it) | Nuovi derivati dell'acido ursodesossicolico | |
IT1198389B (it) | Esteri dell'acido 3-metilflavone-8-carbossilico | |
IT1167479B (it) | Derivati dell'acido chenodesossicolico | |
IT1150726B (it) | Derivati dell'acido ascorbico | |
IT1126405B (it) | Derivati esteri dell'acido farnesilacetico | |
IT1170914B (it) | Derivati sostituiti dell'acido 4-fenil-4-osso-2-idrossibutanoico aventi proprieta' farmaceutiche | |
IT1134423B (it) | Procedimento per la preparazione di derivati di esteri dell'acido apovincaminico | |
IT1157325B (it) | Esteri dell'acido antranilico | |
IT1122310B (it) | Derivati dell'acido tio-propanoilamminico | |
IT7849300A0 (it) | Derivati dell'acido 2-triclorometil4-nitrobenzolsolfenico | |
IT1121530B (it) | Nuovi derivati dell'acido 1-pirrolo-e 1-pirrolidin-carbossilico e procedimento per la loro preparazione | |
IT1141125B (it) | Derivati dell'acido carbotioico di mercaptoacilamminocidi | |
IT7909322A0 (it) | Un procedimento per la produzione dell acido 4 amminobutirico e suoi derivati | |
IT1168089B (it) | Procedimento per la preparazione di derivati dell'acido penem-3-carbossilico | |
IT1195761B (it) | Derivati dell'acido ossayohimban-carbossilico | |
IT1137454B (it) | Derivati dell'acido benzaminoetilfenossicicloesilacetico | |
IT1081510B (it) | Derivati dell'acido 2-cianoesanoico | |
IT1095451B (it) | Esteri dell'acido ciclopropancarbossilico | |
IT1150960B (it) | Derivati dell'acido 4-tiazolidincarbossilico |